What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Sustained abstinence is currently the only accepted end-point for pharmacotherapy trials for most substance use disorders (SUD), with the exception of alcohol. Despite recent efforts, the identification of a non-abstinence alternative as a clinically meaningful end-point for drug use trials has been...
Saved in:
| Hovedforfatter: | |
|---|---|
| Andre forfattere: | |
| Format: | Journal Article |
| Sprog: | engelsk |
| Fag: | |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
Vær først til at give en kommentarø!